New stock news | Sunwoda Electronic (300207.SZ) second submission to the Hong Kong Stock Exchange
According to the disclosure on January 30th by the Hong Kong Stock Exchange, Xindada Electronics Co., Ltd. (referred to as "Xindada", 300207.SZ) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities as its joint sponsors. This is the second time the company has submitted its application to the Hong Kong Stock Exchange.
According to the disclosure by the Hong Kong Stock Exchange on January 30th, Sunwoda Electronic Co. Ltd. (referred to as Sunwoda Electronic, 300207.SZ) has submitted its listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC SEC as its joint sponsors. This is the company's second submission to the Hong Kong Stock Exchange. The prospectus shows that Sunwoda Electronic is a leading lithium battery technology innovation company, dedicated to providing sustainable and efficient new energy integrated solutions. The company is mainly engaged in research, design, manufacturing, and sales of lithium batteries, covering a diversified product matrix including consumer batteries, power batteries, and energy storage systems, and providing customers with comprehensive solutions from battery cells, modules, systems, to battery testing and recycling. According to the total shipment volume of batteries related to mobile phones, laptops, and tablets in 2024, the company has become the world's largest lithium-ion battery manufacturer.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


